Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA.
about
The human non-muscle alpha-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cellsCDO: an oncogene-, serum-, and anchorage-regulated member of the Ig/fibronectin type III repeat familyMutant alpha-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinomaDifferential nuclear translocation and transactivation potential of beta-catenin and plakoglobinGrowth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumorsActopaxin, a new focal adhesion protein that binds paxillin LD motifs and actin and regulates cell adhesionThe vinculin-DeltaIn20/21 mouse: characteristics of a constitutive, actin-binding deficient splice variant of vinculinFibroblast transgelin and smooth muscle SM22alpha are the same protein, the expression of which is down-regulated in many cell linesA zyxin-related protein whose synthesis is reduced in virally transformed fibroblastsMetastasis-association of the rat ortholog of the human epithelial glycoprotein antigen EGP314Identification of genes periodically expressed in the human cell cycle and their expression in tumorsVinexin beta regulates the anchorage dependence of ERK2 activation stimulated by epidermal growth factor.Submembranous junctional plaque proteins include potential tumor suppressor moleculesNeurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton.Gene expression profiling of fibroblasts resistant toward oncogene-mediated transformation reveals preferential transcription of negative growth regulators.Loss of ERα induces amoeboid-like migration of breast cancer cells by downregulating vinculin.A role for Rho in Ras transformation.The dual role of cytoskeletal anchor proteins in cell adhesion and signal transduction.Tight junction protein ZO-2 is differentially expressed in normal pancreatic ducts compared to human pancreatic adenocarcinoma.Targeted disruption of vinculin genes in F9 and embryonic stem cells changes cell morphology, adhesion, and locomotionPost-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts.Reversible tumorigenesis induced by deficiency of vasodilator-stimulated phosphoprotein.Activation of membrane androgen receptors in colon cancer inhibits the prosurvival signals Akt/bad in vitro and in vivo and blocks migration via vinculin/actin signaling.Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancerAniline-induced nitrosative stress in rat spleen: proteomic identification of nitrated proteins.New insights into vinculin function and regulation.Adhesion systems in normal breast and in invasive breast carcinoma.Mono-(2-ethylhexyl) phthalate (MEHP) promotes invasion and migration of human testicular embryonal carcinoma cellsVinculin is required for cell polarization, migration, and extracellular matrix remodeling in 3D collagen.Expression of chicken vinculin complements the adhesion-defective phenotype of a mutant mouse F9 embryonal carcinoma cellRegulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system.Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility.Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1.Occupy tissue: the movement in cancer metastasis.Oncogenic Ras-induced morphologic change is through MEK/ERK signaling pathway to downregulate Stat3 at a posttranslational level in NIH3T3 cells.Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogeneLipid binding to the tail domain of vinculin: specificity and the role of the N and C termini.Tumor suppressor activity of profilin requires a functional actin binding site.Forced expression of tropomyosin 2 or 3 in v-Ki-ras-transformed fibroblasts results in distinct phenotypic effects.Tropomyosin-2 cDNA lacking the 3' untranslated region riboregulator induces growth inhibition of v-Ki-ras-transformed fibroblasts
P2860
Q22011190-F72D0222-CD90-4A32-8637-8D28B2B08EBFQ24316104-F140F4EC-2E52-41AC-A248-F67C97E96A47Q24321856-DD116318-2F99-48F1-9430-75849393574FQ24683009-59E8355D-9984-449E-AA63-D5364B88C136Q24683875-7FDEDFEB-44C3-4FDF-B5F0-38D60FE731A7Q24685749-45BD7A68-4964-40F5-B4BD-D8B6510E2B4DQ27323774-B900431B-0956-404F-AD8D-7D5E6F0451EFQ28255543-8014C8EE-E5C1-4345-90A7-C1D8AABD7EF2Q28296665-02EC44A7-F110-45D5-9C7C-72893F9FA498Q28582145-DC4DF4FF-DA03-4F9B-A83F-EFFEFE675100Q29619131-ED7C25CE-CC91-4E44-A166-3E0BB854659CQ30167641-A2694FD0-09AB-4365-9D57-5432479EC4BDQ30494561-E2B881A0-371A-4A80-BDF5-CD76DDDA644BQ30498854-2C4150E2-2277-4181-9A24-F8B1F4F3C52CQ30779002-CADFDE24-9F7F-4EC2-8948-EF14E504E0ECQ30841338-46290E1C-43BD-4302-A61E-1E61B3A9BC7EQ33723020-B45BA1D7-BA01-4B40-B784-53E05F4C235DQ33833342-15C5EA47-BC11-48B9-80BD-A55AB72EDD1BQ33864266-91AA37B2-9E1B-4DEF-B5FA-823CDE5D7422Q33889491-73E35D98-2BB4-4EF8-BCFA-8599051132E3Q33953392-B00D8290-4F23-4F69-AAE6-D8642E3A537CQ33958096-DD276D88-2E35-4331-9415-10B47230DDEBQ34500702-8A565B9F-8B2F-4EA8-9746-6FE06978A544Q35059908-E47A1FA9-6647-4249-903F-884CDD0A7E5FQ35538384-BD473F2C-58DD-4DDD-8208-2D4BCFC0F2CBQ35591684-7CCA8DF8-81B2-418C-8141-C85E395E4C45Q35794930-F94713D8-0511-4920-A662-6778DD805018Q36000661-18B93EC1-0734-4C30-A25F-30D9B861DCFDQ36171291-EA56E8C7-925A-42DD-93B3-4D2532D4B0C5Q36233310-B09B609A-5C5E-470A-9DA5-BF31D0AE71B1Q36275000-294A6925-D095-4842-B380-217F70A7A320Q36322135-514FE47F-8E51-42D9-9C38-382489047301Q36368457-AF5378DA-E7F3-44BC-80D0-13722FAF74BCQ36394738-4AAA596C-D971-4341-A864-350E2612D245Q36405473-BA00560D-FA88-4F91-8E8D-830E48969B0CQ36447654-2EE4DD54-D3A0-40F1-8B98-FC65A25796D5Q37119768-AE312001-B5EE-4F3C-8CEB-320E4311EE6DQ37220425-5051DC2F-E30A-45CB-AE62-63E4ACDE32E5Q37357833-721E959E-7B82-481E-BB03-407A819BD60BQ37386091-672A6E1C-F048-459E-8077-5383916E7A38
P2860
Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA.
@ast
Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA.
@en
type
label
Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA.
@ast
Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA.
@en
prefLabel
Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA.
@ast
Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA.
@en
P2093
P2860
P356
P1476
Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA.
@en
P2093
Ben-Ze'ev A
Rodríguez Fernández JL
P2860
P304
P356
10.1083/JCB.119.2.427
P407
P577
1992-10-01T00:00:00Z